Harvard Bioscience (HBIO) P/E Ratio
P/E Ratio as of Jun 13, 2025: -0.39
Average-0.3275
Median-0.3100
Minimum-0.5100
Maximum-0.2200
-0.39
Past Month-0.12 (44.44%)
The P/E ratio for Harvard Bioscience (HBIO) is -0.39 as of Jun 13, 2025. This represents a decrease of -93.66% compared to its 12-month average P/E ratio of -6.15. A higher P/E ratio suggests that investors expect strong future earnings growth, while a lower P/E ratio may indicate a potentially undervalued stock or slowing growth.
Harvard Bioscience P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Harvard Bioscience’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Harvard Bioscience to industry peers.
Harvard Bioscience P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Harvard Bioscience’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Harvard Bioscience to industry peers.
Harvard Bioscience (HBIO) P/E Ratio Insights
See Harvard Bioscience’s latest P/E ratio, historical trends, and valuation insights with AI-powered fundamental data and custom analysis.
Start investing in Harvard Bioscience (HBIO)
Order type
Buy in
Order amount
Est. shares
0 shares
Harvard Bioscience (HBIO) P/E Ratio Historic Data
| Date | Stock price | P/E ratio |
|---|---|---|
| Jun 2, 2025 | $0.4054 | -0.31 |
| May 1, 2025 | $0.3401 | -1.19 |
| Apr 1, 2025 | $0.59 | -2.07 |
| Mar 3, 2025 | $0.82 | -2.50 |
| Feb 3, 2025 | $1.65 | -5.03 |
| Jan 2, 2025 | $2.03 | -6.19 |
Harvard Bioscience (HBIO) End of Year P/E Ratio
| Date | P/E ratio | Change |
|---|---|---|
| 2025 | -0.39 | -93.93% |
| 2024 | -6.43 | -90.72% |
| 2023 | -69.30 | +323.59% |
| 2022 | -16.36 | -97.91% |
| 2021 | -783.33 | +3,605.44% |
| 2020 | -21.14 | — |
FAQs About Harvard Bioscience (HBIO) P/E ratio
The latest P/E ratio of Harvard Bioscience (HBIO) is -0.39, as of Jun 13, 2025. This is calculated based on its current stock price and earnings per share (EPS).
Harvard Bioscience’s last 12-month average P/E ratio is -6.15, compared to its current P/E ratio of -0.39. This reflects a decrease of -93.66%.
Harvard Bioscience’s current P/E ratio of -0.39 is lower than its last 12-month average P/E of -6.15. A higher P/E can indicate strong future growth expectations, while a lower P/E might suggest undervaluation.
Harvard Bioscience’s average P/E ratio over the last 3 years is -30.68. Comparing this to the current P/E helps assess recent valuation trends and whether the stock is trading above or below its mid-term historical range.
Harvard Bioscience’s average P/E ratio over the last 5 years is -73.7. A deviation from this historical average may indicate shifts in growth expectations, profitability, or broader market conditions affecting valuation.